Over-the-counter drugs and other  substances used in attempted suicide presented to emergency departments in Montreal, Canada - Mikhail A, Tanoli O, Légaré G, Dubé PA, Habel Y, Lesage A, Low NCP, Lamarre S, Singh S, Rahme E.
BACKGROUND: Over-the-counter (OTC) analgesics are frequently used in suicide attempts. Accessibility, toxicity, and unsupervised acquisition of large amounts may be facilitators. AIMS: To identify patient characteristics associated with OTC drug use as a s... (Source: SafetyLit)
Source: SafetyLit - September 21, 2018 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

What you should know about today ’ s top trends in medtech
Medtech’s hottest topics in M&A, intellectual property, finance and regulation will be on the agenda at DeviceTalks Boston Oct. 8-11. Patent attorney David Dykeman from the Boston office of the global law firm Greenberg Traurig will moderate the Oct. 9 hot topics panel in which the discussion will center around: · M&A trends from the perspective of both the acquirer and seller · IP protection as the key to a successful exit · Financing best practices from early stage to exit · Regulatory trends and best practices Get the full story on our sister site, Medical Design &...
Source: Mass Device - September 21, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Business/Financial News Featured Food & Drug Administration (FDA) Health Information Technology Mergers & Acquisitions Regulatory/Compliance Software / IT Allied Minds altariscapitalpartners Analogic augmenix Boston Scientific Source Type: news

Why an Exton pharma firm will benefit from Almirral's $550M deal with Allergan
Almirall SA has finalized its $550 million acquisition of four approved products and one new drug candidate from Allergan's medical dermatology unit in  the United States. The acquisition bolsters the presence of Almirall, which is based in Barcelona, Spain, in the U.S. dermatology market through its Exton-based subsidiary Aqua Pharmaceuticals. Almirall acquired Aqua in 2013 in a deal valued at up to $400 million. Aqua makes and markets a variet y of product for skin disorders including acne, eczema,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 21, 2018 Category: Biotechnology Authors: John George Source Type: news

How strong patent portfolios attract strategic investments and deals
Amassing strong patent portfolios helps medical device companies attract interest from strategic investors and potential acquirers. David J. Dykeman, Greenberg Traurig and Patrick West, Mirus Capital Advisors [Image from unsplash.com]The medical device industry has demonstrated strong and sustainable growth in recent years. Given the aging population, increasing incidence of chronic and lifestyle diseases, emergence of artificial intelligence (AI) and big data, and significant investments in R&D and M&A, the medtech sector appears to be in prime health. According to KPMG, the medical device industry’s gl...
Source: Mass Device - September 21, 2018 Category: Medical Devices Authors: Chris Newmarker Tags: Business/Financial News Mergers & Acquisitions Wall Street Beat DeviceTalks Boston devicetalksboston Greenberg Traurig intellectualproperty Mirus Capital Source Type: news

Weekly Postings
See something of interest? Please share our postings with colleagues in your institutions! Spotlight September is National Preparedness Month. Disasters Happen. Prepare Now. Learn How. This week: Check your coverage. The Fall 2018 offering for The Health Sciences Library Association of New Jersey’s Group Licensing Initiative (HSLANJ GLI) is now available. MAR members are eligible for this cost-saving opportunity! The deadline to participate is Friday, November 9. Learn more. National Network of Libraries of Medicine News Funding Available: NNLM MAR has funding available for two grants of $19,000. Libraries, community...
Source: NN/LM Middle Atlantic Region Blog - September 21, 2018 Category: Databases & Libraries Authors: Hannah Sinemus Tags: Weekly Postings Source Type: news

Medtronic and Mazor will Tie the Knot in a $1.6B Deal
Medtronic made a big move back in May 2016 by inking a major multi-phased strategic and equity investment agreement with Mazor Robotics. Today the pair made that relationship even more official by announcing that Medtronic will acquire Mazor. The cash deal is valued at about $1.64 billion, or $1.34 billion net of Medtronic's existing stake in Mazor and cash acquired. Considering Mazor's revenue took a big hit in the second quarter due to lower pricing under its agreement with Medtronic, the acquisition is easily a win-win for both companies. It's also no coincidence that the deal was unveiled just d...
Source: MDDI - September 21, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Orthopedics Source Type: news

Almirall acquires Allergan U.S. medical dermatology portfolio*
Portfolio includes four available therapies for acne and dermatoses and an investigational compound currently under FDA review Agreement enhances Almirall's portfolio in the U.S. and emphasizes long-term commitment to the dermatology community EXTON,... Biopharmaceuticals, Dermatology, Acquisitions Almirall, Allergan, Aczone, Tazorac, Azelex, Cordran (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 21, 2018 Category: Pharmaceuticals Source Type: news

Pressure Mounts On Rite Aid To Find A Partner
Rite Aid faces intensifying pressure to find a strategic partner one month after its merger with Albertsons fell apart. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 21, 2018 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Tags: NASDAQ:WBA NASDAQ:ESRX NYSE:CVS NYSE:RAD NYSE:WMT Source Type: news

Medtronic is all-in on surgical robotics with $1.6B Mazor buy
Medtronic (NYSE:MDT) is all-in on the surgical robotics game now that’s inked a deal to buy Mazor Robotics (NSDQ:MZOR) for more than $1.6 billion in cash. The world’s largest medical device maker has held a position in Mazor, which makes the Mazor X guidance system and the Renaissance robot-assisted spine surgery platform, since May 2016. In September they closed the third, $40 million tranche of the investment, giving Medtronic a 10.6% stake it paid $72 million for. Now all of the Fridley, Minn.-based company’s chips are in the pot with the $58.50-per ADR share offer to acquire Mazor,...
Source: Mass Device - September 21, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Featured Mergers & Acquisitions Robotics Wall Street Beat mazorrobotics Medtronic Source Type: news

Covalon to acquire Cenorin ’ s AquaGuard for $12m
Covalon Technologies said today it inked a definitive agreement to acquire Cenorin’s AquaGuard division in a deal worth approximately $12.4 million (CAD $16.1 million). AquaGuard develops products intended to provide patients with moisture protection for wound, surgical and vascular access sites during showers, Ontario-based Covalon said. Current AquaGuard CEO Gerry Arambula and existing leadership at the company will continue to “play key roles in leading the business going forward,” according to a press release. Covalon said that with the acquisition, it will have a customer base of over 1,500 hosp...
Source: Mass Device - September 20, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Mergers & Acquisitions Wound Care cenorin Covalon Technologies Source Type: news

Report: Google ’s Nest looking to expand into healthcare
Connected home device maker Nest, which was bought by Google (NSDQ:GOOG) in 2014 for $3.2 billion, acquired smartphone-based health monitoring system developer Senosis Health last year in a hush-hush deal that may mark the business’ first steps towards an entry into the healthcare market, according to a GeekWire report. When the deal was initially reported last year, only Google was identified as having picked up the University of Washington spin-out focused on health monitoring. In its recent report, GeekWire said that the secrecy last year was intentional, and that Google’s Nest was the actual buyer in t...
Source: Mass Device - September 20, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Diagnostics Featured Mergers & Acquisitions Software / IT google nest Source Type: news

The 10 largest medical device companies in the world
Medtronic and Johnson & Johnson remain the world’s largest medical device companies. But after that, the roster is radically shifting amid a slew of mergers and acquisitions. In some cases such as GE, Philips and Siemens, major multinationals are breaking apart. We’ve sifted through data from public companies’ annual reports and other publicly disclosed information, with attempts to contact companies for additional information — all to create our annual Big 100 list of the world’s major medtech companies. Earlier this week, we counted down Nos. 20–11. Today, it’s the ...
Source: Mass Device - September 20, 2018 Category: Medical Devices Authors: Chris Newmarker Tags: Business/Financial News Mergers & Acquisitions Cardinal Health Danaher Corp. Fresenius GE Healthcare Henry Schein Medical johnsonandjohnson Medtronic philipshealthcare Siemens Healthineers Stryker Source Type: news

Report: Internal Google documents suggest Nest wants to expand into new health products
Alphabet Inc.-owned smart thermostat division Nest quietly drove the 2017 acquisition of Seattle-based Senosis Health, suggesting Nest has bigger ambitions than smart home devices, GeekWire reports. The news outlet reviewed public documents related to the startup’s sale to Google. Those documents reveal Nest was obsessed with secrecy around the acquisition, and negotiated with Senosis’ founders and the University of Washington, which incubated the startup, about when, how and whether to a nnounce… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 20, 2018 Category: Pharmaceuticals Authors: Luke Stangel Source Type: news

An epidemiological study of child neglect and abuse in Italy: an undervalued problem of public health but also an unknown reality - Ferrara P, Michela P, Annunziata F, de Lucia A, Ianniello F, Chiaretti A.
We reported ne... (Source: SafetyLit)
Source: SafetyLit - September 20, 2018 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Australian Competition and Consumer Commission clears Arrow and Apotex merger: Strides
In May 2018, Strides Pharma Science Ltd announced their intention to merge Arrow Pharmaceuticals and Apotex Australia into a new company. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 20, 2018 Category: Pharmaceuticals Source Type: news

Fossils reveal the complex evolutionary history of the mammalian regionalized spine
A unique characteristic of mammals is a vertebral column with anatomically distinct regions, but when and how this trait evolved remains unknown. We reconstructed vertebral regions and their morphological disparity in the extinct forerunners of mammals, the nonmammalian synapsids, to elucidate the evolution of mammalian axial differentiation. Mapping patterns of regionalization and disparity (heterogeneity) across amniotes reveals that both traits increased during synapsid evolution. However, the onset of regionalization predates increased heterogeneity. On the basis of inferred homology patterns, we propose a "pector...
Source: ScienceNOW - September 20, 2018 Category: Science Authors: Jones, K. E., Angielczyk, K. D., Polly, P. D., Head, J. J., Fernandez, V., Lungmus, J. K., Tulga, S., Pierce, S. E. Tags: Evolution, Paleontology reports Source Type: news

Columbus retirement community operator acquires Dayton-area complex
Ohio Living has grown to 13 retirement communities around the state with its latest acquisition. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 19, 2018 Category: American Health Authors: Tristan Navera Source Type: news

Fitbit announces Fitbit Care service, new Fitbit Plus app
Born directly from its acquisition of Twine Health earlier this year, Fitbit Care is a connected health platform for health plans, employers, and health systems. (Source: mobihealthnews)
Source: mobihealthnews - September 19, 2018 Category: Information Technology Source Type: news

Channel Medsystems sues Boston Scientific over spiked $275m buyout
Channel Medsystems sued Boston Scientific (NYSE:BSX) this week over a $275 million buyout that Boston allegedly spiked over a former Channel employee’s alleged scheme to embezzle nearly $3 million from the women’s health company. Emeryville, Calif.-based Channel Medsystems developed Cerene, a cryogen-based endometrial ablation system designed to treat heavy menstrual bleeding that won CE Mark approval in the European Union in June 2017. In the U.S., the treatment phase is complete in a 242-woman pivotal investigational device exemption trial. The company has raised at least $47.6 million in ...
Source: Mass Device - September 19, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Featured Legal News Mergers & Acquisitions Wall Street Beat Boston Scientific Channel Medsystems Source Type: news

A little labeling goes a long way
(Northwestern University) New research from Northwestern University reveals that infants can use even a few labeled examples to spark the acquisition of object categories. Those labeled examples lead infants to initiate the process of categorization, after which they can integrate all subsequent objects, labeled or unlabeled, into their evolving category representation. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - September 19, 2018 Category: International Medicine & Public Health Source Type: news

Public Library Spotlight: Erin Lewis, Acquisitions and Interlibrary Loan, McCracken County Public Library
Name: Erin Lewis Title: Acquisitions and Interlibrary loan Education: Nearing the end of my MSLS degree How did you become interested in focusing on Health and Wellness? Exercise and being active plays a vital role in my life. I feel so much better when I exercise and I want to help others realize the benefits of an active lifestyle. What’s the impact that you hope to make in your community? I hope to help my community find ways to incorporate exercise into everyday life. What is your favorite health related program or outreach that you’ve done?  Pedal in Paducah. I love to ride my bicycle and was so ex...
Source: The Cornflower - September 18, 2018 Category: Databases & Libraries Authors: Bobbi Newman Tags: Public Libraries Public Libraries Spotlight Source Type: news

The 20 largest medical device companies in the world
The medical device industry saw even more consolidation over the past year, as evidenced by Medical Design & Outsourcing‘s newest Big 100 list. It used to be that a company had to have at least $100 million in annual revenue to make it on the list. This time around, No. 100 on the list is EDAP (Vaulx-en-Velin, France) with the equivalent of $40.4 million in revenue. All the while, the frenzy of mergers and acquisitions makes for a dynamic list. Today, we’re going to count down Nos. 20–11 on the list. First thing Thursday, we’ll post the top 10. Read on to find out important information about the...
Source: Mass Device - September 18, 2018 Category: Medical Devices Authors: Chris Newmarker Tags: Business/Financial News Featured Mergers & Acquisitions Wall Street Beat 3m Abbott Alcon B. Braun Baxter BD bectondickinson Boston Scientific Essilor Novartis Owens & Minor zimmerbiomet Source Type: news

Will Elliott pay top dollar for athenahealth? Analysts aren't optimistic
Analysts are losing faith that athenahealth Inc. will sell for above $160 a share, following reports that Elliott Management isn't willing to pay that much for the Watertown-based health IT company. In a note on Tuesday, Leerink Research analyst David Larsen said he is “cautious” on athenahealth’s (NASDAQ: ATHN) potential acquisition price, given a New York Post report that Elliott has "backed away" from the $160-per-share offer it publicly made back in May. According to the Post report , which… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 18, 2018 Category: Pharmaceuticals Authors: Jessica Bartlett Source Type: news

Zavation, PanMed join forces in spinal device market
Spinal hardware and biologics company Zavation Medical Products (Jackson, Miss.) said today that it has partnered with the management team of Pan Medical U.S. Corp. to buy that company. PanMed (Tampa, Fla.) designs, develops and manufactures highly complex medical products including balloons, catheters, needles, and instrument kits used in minimally invasive procedures, primarily in kyphoplasty and interventional radiology. The company was founded in the U.K.  30 years ago and relocated to the U.S. in 2016. Get the full story on our sister site, Medical Design & Outsourcing. The post Zavation, PanMe...
Source: Mass Device - September 18, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Business/Financial News Implants Mergers & Acquisitions Orthopedics Spinal Surgical panmedical zavationmedical Source Type: news

Merger of Cigna and Express Scripts Gets Approval From Justice Dept.
The takeover of one of the nation ’ s largest pharmacy benefit manager by a big health insurer is expected to close by the end of the year. (Source: NYT Health)
Source: NYT Health - September 17, 2018 Category: Consumer Health News Authors: REED ABELSON Tags: Health Insurance and Managed Care Mergers, Acquisitions and Divestitures Drugs (Pharmaceuticals) CVS Caremark Corporation Express Scripts Inc CIGNA Corporation Justice Department Antitrust Laws and Competition Issues Source Type: news

Justice Department Approves Cigna-Express Scripts Merger
The takeover of one of the nation ’ s largest pharmacy benefit managers by a big health insurer is expected to close by the end of the year. (Source: NYT Health)
Source: NYT Health - September 17, 2018 Category: Consumer Health News Authors: REED ABELSON Tags: Health Insurance and Managed Care Mergers, Acquisitions and Divestitures Drugs (Pharmaceuticals) CVS Caremark Corporation Express Scripts Inc CIGNA Corporation Justice Department Antitrust Laws and Competition Issues Source Type: news

U.S. approves Express Scripts-Cigna merger
Cigna's $54 billion purchase of North County-based Express Scripts is one step closer to completion after the U.S. Department of Justice on Monday approved the deal. The sale is still contingent on state regulatory approvals and the satisfaction of closing conditions, the companies said, adding that they expect the deal to close this year. “We are pleased that the Department of Justice has cleared our transaction and that we are another step closer to compl eting our merger and delivering greater… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 17, 2018 Category: Pharmaceuticals Authors: Jacob Kirn Source Type: news

U.S. approves Express Scripts-Cigna merger
Cigna's $54 billion purchase of North County-based Express Scripts is one step closer to completion after the U.S. Department of Justice on Monday approved the deal. The sale is still contingent on state regulatory approvals and the satisfaction of closing conditions, the companies said, adding that they expect the deal to close this year. “We are pleased that the Department of Justice has cleared our transaction and that we are another step closer to compl eting our merger and delivering greater… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 17, 2018 Category: Biotechnology Authors: Jacob Kirn Source Type: news

DoJ clears Cigna’s $67bn acquisition of Express Scripts
(Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - September 17, 2018 Category: Pharmaceuticals Source Type: news

Justice Department Gives Early Okay To Cigna-Express Scripts Deal
U.S. Justice Department has cleared the Cigna and Express Scripts merger, " terminating the applicable waiting period, " the companies said Monday. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 17, 2018 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Tags: NASDAQ:ESRX NYSE:CVS NYSE:CI NYSE:AET NYSE:UNH Source Type: news

Waystar to acquire Massachusetts tech firm
A local health care business-services company is growing through another merger. Louisville-based Waystar, formerly was known as ZirMed Inc., has agreed to acquire Waltham, Mass.-based Connance Inc. Terms of the deal were not disclosed. But the combined company will operate under the Waystar name and will have offices in Louisville, Chicago, Atlanta and Boston, according to a news release. Jim Lacy, Waystar's chief strategy officer and counsel, said in an interview that the acquisition will… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 17, 2018 Category: American Health Authors: Chris Larson Source Type: news

Relias acquisition means more jobs in Cary
Fast-growing Relias, a Cary company focused on training in the health care space, has made another acquisition – and one that the CEO says will translate to more jobs in the Triangle. Relias announced Monday that it has acquired the health care division of OnCourse, a 60-year-old company based in Brookfield, Wisconsin. Relias CEO Jim Triandiflou declined to give specifics on the cost but said it was the largest price the company has paid in any of its multiple acquisitions. He said conversations… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - September 17, 2018 Category: Health Management Authors: Dane Huffman Source Type: news

Relias acquisition means more jobs in Cary
Fast-growing Relias, a Cary company focused on training in the health care space, has made another acquisition – and one that the CEO says will translate to more jobs in the Triangle. Relias announced Monday that it has acquired the health care division of OnCourse, a 60-year-old company based in Brookfield, Wisconsin. Relias CEO Jim Triandiflou declined to give specifics on the cost but said it was the largest price the company has paid in any of its multiple acquisitions. He said conversations… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 17, 2018 Category: Biotechnology Authors: Dane Huffman Source Type: news

Smiths Medical won't be sold after all; parent company calls off merger talks
Smiths Group has called off talks that could have resulted in the merger of its Minnesota-based medical-device unit with a California company. In a statement, London-based Smiths said it and San Clemente, Calif.-based ICU Medical Inc. couldn’t agree on terms of a deal.  “Smiths Medical will continue to capitalize on the increased investment that it is making in new product development,” said Andy Reynolds Smith, CEO of Smiths Gro up, in a news release. “We remain confident that our strategy… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 14, 2018 Category: Biotechnology Authors: Katharine Grayson Source Type: news

Smiths Medical won't be sold after all; parent company calls off merger talks
Smiths Group has called off talks that could have resulted in the merger of its Minnesota-based medical-device unit with a California company. In a statement, London-based Smiths said it and San Clemente, Calif.-based ICU Medical Inc. couldn’t agree on terms of a deal.  “Smiths Medical will continue to capitalize on the increased investment that it is making in new product development,” said Andy Reynolds Smith, CEO of Smiths Gro up, in a news release. “We remain confident that our strategy… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 14, 2018 Category: American Health Authors: Katharine Grayson Source Type: news

Montco medical device company acquires New York developer of surgical planning software
Montgomery County medical device manufacturer Globus Medical has acquired Nemaris Inc., a New York City company that develops and markets surgical planning software. Financial terms of the deal were not disclosed. Globus, of Audobon, Pa. specialize in products and technology used in musculoskeletal and spine surgeries. Dave Demski, the CEO of Globus, said the acquisition of Nemaris and its Surgimap platform — which allows health care professionals to simul ate potential surgical outcomes and… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 14, 2018 Category: Pharmaceuticals Authors: John George Source Type: news

Allergan to Acquire Bonti Adding New Neurotoxin Programs to Medical Aesthetics Pipeline
Acquisition Adds Fast-Acting Neurotoxin Programs with 2 to 4-Week Duration to Allergan's Best-in-Class Medical Aesthetics Portfolio and Pipeline DUBLIN and NEWPORT BEACH, Calif., Sept. 14, 2018 -- (Healthcare Sales & Marketing Network) -- Allergan plc ... Biopharmaceuticals, Dermatology, Mergers & Acquisitions Allergan, Bonti, botulinum neurotoxin, BoNT/E, botulinum (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 14, 2018 Category: Pharmaceuticals Source Type: news

Smiths Medical spikes merger talks with ICU Medical
Smiths Group (LON:SMIN) said yesterday that it’s spiking merger talks with ICU Medical (NSDQ:ICUI) after rejecting a nearly $4 billion offer earlier this month. The British company and San Clemente, Calif.-based ICU revealed negotiations in May about a possible union with Smiths Medical. Smiths, said to be eyeing the exit door last month, reportedly rejected a cash-and-stock offer worth $3.67 billion (£2.8 billion) in early September. Get the full story at our sister site, Drug Delivery Business News. The post Smiths Medical spikes merger talks with ICU Medical appeared first on Ma...
Source: Mass Device - September 14, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Featured Hospital Care Mergers & Acquisitions Wall Street Beat ICU Medical Inc. Smiths Medical Source Type: news

Globus Medical picks up Surgimap for ExcelsiusGPS robot-assisted surgery device
Globus Medical (NYSE:GMED) said yesterday that it acquired Nemaris and its Surgimap planning software for an undisclosed amount. Globus said it plans to integrate New York City-based the Nemaris tech into its ExcelsiusGPS robot-assisted surgery platform. “The acquisition of Surgimap bolsters Globus Medical’s efforts to advance the future of computer-assisted surgery with the goal of improving patient outcomes,” CEO Dave Demski said in prepared remarks. “Software-enhanced solutions are critical components of the future of computer-assisted surgery, and Surgimap is the leading surgical planning s...
Source: Mass Device - September 14, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Featured Mergers & Acquisitions Globus Medical Nemaris Source Type: news

Optical group grows to 17 sites with acquisition of Buffalo Optical
The Hamburg optical group has grown to 17 stores across the Buffalo-Rochester market, and now will begin adding sites inside Tops Friendly Markets. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 14, 2018 Category: American Health Authors: Tracey Drury Source Type: news

AngioDynamics Acquires RadiaDyne for an Undisclosed Sum
It continues to be a busy week for M&A in the medtech industry. This time around AngioDynamics is making a play to acquire RadiaDyne, the developer of a radiation dose monitoring platform, for an undisclosed sum. The deal is set to close at the end of September. This transaction expands Latham, NY-based AngioDynamics’ growing Oncology business by adding RadiaDyne’s early-stage, OARtrac real-time radiation dose monitoring platform and other market-leading oncology solutions, including the IsoLoc/ImmobiLoc and Alatus balloon stabilizing technologies. The acquisition follows AngioDynami...
Source: MDDI - September 13, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Doylestown Health receives $1M state grant for expansion project
Doylestown Health received a $1 million state grant to support the development of its $42 million Center for Heart and Vascular Care currently under construction at its Bucks County campus. The Redevelopment Assistance Capital Program grant was secured with the help of state Rep. Marguerite Quinn and state Sen. Chuck McIlhinney. The program, administered by the state Office of the Budget, provides funding for the acquisition and construction of regional economic, cultural, civic, rec reational and… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 13, 2018 Category: Biotechnology Authors: John George Source Type: news

Agfa-Gevaert declines buyout offer from Kanteron
Agfa-Gevaert has responded with a "thanks, but no thanks" to an unsolicited...Read more on AuntMinnie.comRelated Reading: Agfa receives acquisition offer from health IT firm Agfa completes South Carolina PACS project Agfa completes enterprise imaging installation in Texas Agfa wins Md. digital x-ray contract Strong euro takes bite out of Agfa Q1 revenue (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 13, 2018 Category: Radiology Source Type: news

Benvenue Medical deals vertebral augmentation assets to IZI Medical Products
Benvenue Medical said today it divested its vertebral augmentation systems portfolio to IZI Medical Products for an undisclosed amount. The divested assets include Benvenue’s Kiva VCF treatment system, the Kiva Pilot and Blazer vertebral augmentation system devices, Santa Clara, Calif.-based Benvenue Medical said. Benvenue said that with the sale, the company will focus on its Luna 3D interbody fusion system, and that it will continue its surgeon-focused spine device development and US operations. “IZI Medical’s acquisition of the Kiva and associated VCF product franchise allows us to singularly focus on ...
Source: Mass Device - September 13, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Spinal Benvenue Medical Inc izimedical Source Type: news

AngioDynamics to acquire radiation dose tech dev RadiaDyne
AngioDynamics (NSDQ:ANGO) said today that it inked a deal to acquire dose monitoring tech developer RadiaDyne for an undisclosed amount. The deal will add RadiaDyne’s early-stage OARtrac real-time radiation dose monitoring platform and its IsoLoc, ImmobiLoc and Alatus balloon stabilizing technologies to Latham, N.Y.-based AngioDynamic’s oncology portfolio, the company said. “The acquisition of RadiaDyne, combined with our recent BioSentry asset purchase, delivers on our commitment to build a world-class oncology portfolio. We believe that together, these disruptive, patient-focused technologies will ...
Source: Mass Device - September 13, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Mergers & Acquisitions Oncology AngioDynamics radiadyne Source Type: news

BI Joins Pharma Frenzy For Cancer-Killing Viruses With $244M Acquisition
With its purchase of ViraTherapeutics, German's Boehringer Ingelheim joins a large and growing list of Big Pharma companies investing in viruses that are engineered to seek out and destroy cancer. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 13, 2018 Category: Pharmaceuticals Authors: Arlene Weintraub, Contributor Source Type: news

AngioDynamics expands oncology business with RadiaDyne acquisition
Medical device maker AngioDynamics is expanding its oncology business with the acquisition of RadiaDyne in Houston. RadiaDyne generates $6 million a year in sales designing patient dosage monitoring systems. The acquisition is expected to close at the end of September. Terms were not disclosed. The transaction comes as AngioDynamics consolidates and expands its oncology business at its Glens Falls, New York, m anufacturing complex. Oncology is the smallest, but fastest-growing of AngioDynamics… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 13, 2018 Category: Pharmaceuticals Authors: Robin K. Cooper Source Type: news

Latin America Offers Sound Diagnosis For E-Health Investors
As Latin America ’s population ages, e-health companies that help patients, doctors and health care providers connect and reduce costs are on the rise. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 12, 2018 Category: Pharmaceuticals Authors: Mergermarket, Contributor Source Type: news

J & amp;J Takes Break from Divestitures and Hops on M & amp;A Trail
Apparently two things happen in September: Football season comes back in full swing, and medtech acquisitions begin to pick up. For the third time this week, a new medtech deal has been announced from a larger player in the game. This time out, Johnson & Johnson, through a subsidiary, is acquiring Emerging Implant Technologies Gmbh (EIT), a privately held manufacturer of 3D-printed titanium interbody implants for spinal fusion surgery, for an undisclosed sum. This acquisition allows DePuy Synthes, the orthopedics business of Johnson & Johnson, to enhance its interbody implant portfolio that includes exp...
Source: MDDI - September 12, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Orthopedics Source Type: news

Denver health-tech firm expands into Medicaid market with acquisition
One of Denver ’s fastest-growing health information-technology companies has made an acquisition that company officials say will help it get a slice of new markets. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 12, 2018 Category: Pharmaceuticals Authors: Andrew Dodson Source Type: news